Evolving intelligence, Infinite creativity.
BioGeometry engineers the molecules of tomorrow through self-evolving intelligence.
Bridging molecules and cells for drug discovery
GeoFlow
Molecular world model
Rapid, accurate, and general molecular design
Atomic modeling unifies structure prediction and de novo design, generating diverse candidate molecules for complex drug targets.
GeoCell
Virtual cell model
More realistic simulation of cellular mechanisms
Models cellular states and responses to perturbation, supporting target discovery, indication exploration, and patient stratification.
RSI4Bio: A Self-Improving Protein Design Engine
Every experiment sets the next evolution in motion.
GeoFlow
GeoFlowCode
GeoLab
Model parametersCandidate moleculesExperimental data
R&D Pipelines
Driving innovative pipelines with evolving intelligence
Therapeutics Pipelines
We translate unmet drug development needs into computational design objectives, continually generating differentiated molecules.
Synthetic Biology
AI powers enzyme design, process optimization, and scale-up validation, with multiple products advancing rapidly toward commercialization.
Partnership
Licensing, joint R&D, and platform collaboration.
Asset Licensing
Existing pipeline assets and data packages, licensed for continued development.
Co-Development
Joint development from your target or process objective to a validated candidate.
Platform Licensing
Integrated AI design and wet-lab capabilities, licensed across multiple programs.